Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 209
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Editor’s Choice Award 2021-Best Study on Psychedelics and Nature
PT276 – Micah Haskell-Hoehl – Healing, Equity, and Federal Policy
Psychedelic Bulletin: MAPS’ $70m Investment Vehicle; atai’s Increased Stake in COMPASS;...
Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board
Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial...
Michael Falvey joins COMPASS Pathways as Chief Financial Officer
Silo Pharma Announces Grant of U.S. Patent For its Novel CNS...
The Wild World of 19th Century Psychedelics
PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE
Load more